Interaction of Osteopontin with IL-18 in Obese Individuals: Implications for Insulin Resistance

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Ahmad, Rasheed ^a   Al Mass, Anfal ^a   Al Ghawas, Dalal ^a   Shareif, Nada ^a   Zghoul, Nadia ^a   Melhem, Motasem ^a   Hasan, Amal ^a   Al Ghimlas, Fahad ^a   Dermime, Said ^a   Behbehani, Kazem ^a  

^a DASMAN DIABETES INSTITUTE   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; OSTEOPONTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; MALE; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-18; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; OBESITY; OSTEOPONTIN; SUBCUTANEOUS FAT, ABDOMINAL;

EID: 84877659899     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063944     Document Type: Article

References (45)

1. Greenberg AS, Obin MS, (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83: 461S-465S.
2. Shoelson SE, Lee J, Goldfine AB, (2006) Inflammation and insulin resistance. The Journal of Clinical Investigation 116: 1793-1801.
3. Lyon CJ, Law RE, Hsueh WA, (2003) Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144: 2195-2200.
4. Hotamisligil GS, Shargill NS, Spiegelman BM, (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
5. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, et al. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82: 4196-4200.
6. Blackburn P, Despres JP, Lamarche B, Tremblay A, Bergeron J, et al. (2006) Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) 14: 1747-1754.
7. Eder K, Baffy N, Falus A, Fulop AK, (2009) The major inflammatory mediator interleukin-6 and obesity. Inflamm Res 58: 727-736.
8. Gustafson B, (2010) Adipose Tissue, Inflammation and Atherosclerosis. J Atheroscler Throm 17: 332-41.
9. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
10. Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, et al. (2004) From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53: 1285-1292.
11. Patarca R, Freeman GJ, Singh RP, Wei FY, Durfee T, et al. (1989) Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med 170: 145-161.
12. Kawamura K, Iyonaga K, Ichiyasu H, Nagano J, Suga M, et al. (2005) Differentiation, maturation, and survival of dendritic cells by osteopontin regulation. Clin Diagn Lab Immunol 12: 206-212.
13. Sodek J, Batista Da Silva AP, Zohar R, (2006) Osteopontin and mucosal protection. J Dent Res 85: 404-415.
14. Bellahcene A, Castronovo V, Ogbureke KU, Fisher LW, Fedarko NS, (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer 8: 212-226.
15. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M, (1998) Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152: 353-358.
16. Nystrom T, Duner P, Hultgardh-Nilsson A, (2007) A constitutive endogenous osteopontin production is important for macrophage function and differentiation. Exp Cell Res 313: 1149-1160.
17. Murry CE, Giachelli CM, Schwartz SM, Vracko R, (1994) Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol 145: 1450-1462.
18. Schack L, Stapulionis R, Christensen B, Kofod-Olsen E, Skov Sorensen UB, et al. (2009) Osteopontin enhances phagocytosis through a novel osteopontin receptor, the alphaXbeta2 integrin. J Immunol 182: 6943-6950.
19. Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, et al. (2007) Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 117: 2877-2888.
20. Boraschi D, Dinarello CA, (2006) IL-18 in autoimmunity: review. Eur Cytokine Netw 17: 224-252.
21. Esposito K, Pontillo A, Ciotola M, Di Palo C, Grella E, et al. (2002) Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 87: 3864-3866.
22. Zhao W, Wang L, Zhang M, Wang P, Zhang L, et al. (2011) NF-kappaB- and AP-1-mediated DNA looping regulates osteopontin transcription in endotoxin-stimulated murine macrophages. J Immunol 186: 3173-3179.
23. Greene CM, Meachery G, Taggart CC, Rooney CP, Coakley R, et al. (2000) Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis. J Immunol 165: 4718-4724.
24. Sahar S, Dwarakanath RS, Reddy MA, Lanting L, Todorov I, et al. (2005) Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis. Circ Res 96: 1064-1071.
25. Reddy VS, Prabhu SD, Mummidi S, Valente AJ, Venkatesan B, et al. (2010) Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation. Am J Physiol Heart Circ Physiol 299: H1242-1254.
26. Gomez-Ambrosi J, Catalan V, Ramirez B, Rodriguez A, Colina I, et al. (2007) Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 92: 3719-3727.
27. Zeyda M, Gollinger K, Todoric J, Kiefer FW, Keck M, et al. (2011) Osteopontin is an activator of human adipose tissue macrophages and directly affects adipocyte function. Endocrinology 152: 2219-2227.
28. Leick L, Lindegaard B, Stensvold D, Plomgaard P, Saltin B, et al. (2007) Adipose tissue interleukin-18 mRNA and plasma interleukin-18: effect of obesity and exercise. Obesity (Silver Spring) 15: 356-363.
29. Osborn O, Gram H, Zorrilla EP, Conti B, Bartfai T, (2008) Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance. Swiss Med Wkly 138: 665-673.
30. Ahmad A, Ahmad R, Toma E, Morisset R, Menezes J, (2000) Impaired induction of IL-15 in response to herpes simplex virus type 1 infection in peripheral blood mononuclear cells of HIV-infected patients. AIDS 14: 744-746.
31. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
32. Bertola A, Deveaux V, Bonnafous S, Rousseau D, Anty R, et al. (2009) Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver steatosis in morbid obesity. Diabetes 58: 125-133.
33. Kiefer FW, Zeyda M, Gollinger K, Pfau B, Neuhofer A, et al. (2010) Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 59: 935-946.
34. Bruun JM, Stallknecht B, Helge JW, Richelsen B, (2007) Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol 157: 465-471.
35. Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF, (2004) Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol Gastrointest Liver Physiol 287: G264-273.
36. Yu Q, Vazquez R, Khojeini EV, Patel C, Venkataramani R, et al. (2009) IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice. Am J Physiol Heart Circ Physiol 297: H76-85.
37. Ogawa D, Stone JF, Takata Y, Blaschke F, Chu VH, et al. (2005) Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways. Circ Res 96: e59-67.
38. Shinohara ML, Jansson M, Hwang ES, Werneck MB, Glimcher LH, et al. (2005) T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc Natl Acad Sci U S A 102: 17101-17106.
39. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, et al. (2000) Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 287: 860-864.
40. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116: 1494-1505.
41. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, et al. (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281: 26602-26614.
42. Hak AE, Pols HA, Stehouwer CD, Meijer J, Kiliaan AJ, et al. (2001) Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab 86: 4398-4405.
43. Hung J, McQuillan BM, Chapman CM, Thompson PL, Beilby JP, (2005) Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol 25: 1268-1273.
44. Zhang YF, Yang YS, Hong J, Gu WQ, Shen CF, et al. (2006) Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 29: 419-423.
45. Sun L, Hu FB, Yu Z, Li H, Liu H, et al. (2011) Lean body mass, interleukin 18, and metabolic syndrome in apparently healthy Chinese. PLoS One 6: e18104.